SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Stockjet who wrote (1414)4/22/1998 9:45:00 PM
From: Bill Jackson  Read Replies (1) | Respond to of 9523
 
We are caught in a catch 22 situation do we stay or do we go. I am not sure if I made myself clear the information that I just heard was not from a guy that handles a few dollars in the market but his portfolio that he run for just one company is 600 million. That is all in the biotech.



To: Stockjet who wrote (1414)4/22/1998 9:45:00 PM
From: Anthony Wong  Respond to of 9523
 
Frankly, I don't believe this. This falsification/tampering of clinical data is a very serious offence. Unless the Wall Street Journal has some hard evidence, I don't think they'll just report a rumour. As for Pfizer doing such a thing, it really boggles my mind.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News